Since the clinical rise of endoscopic ultrasound beginning in the 1980s, the field has rapidly grown from a diagnostic, high-fidelity, cancer-staging modality into a therapeutic platform encompassing novel lumen-to-lumen anastomosis creation, postoperative complication management, tumor ablation, angiotherapy, and beyond.
Many of the inventions driving innovation in EUS-guided therapies have been the result of clinicians